Tenaya Therapeutics, Inc. (TNYA) AI Dilution Summary

Cash was $78,085,000 at 2026-06-30 against estimated monthly burn of $1,184,000. The company's funding channel is an ATM program with Leerink Partners LLC, authorised to $75,000,000. A total of 1,358,333 shares have been sold under it since the program began, through 2025-12-11, and sales after 2025-12-11 have not yet been reported.